- Home
- COLD vs BLCO Comparison
COLD vs BLCO Comparison
Compare COLD & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLD
- BLCO
- Stock Information
- Founded
- COLD 1903
- BLCO 1853
- Country
- COLD United States
- BLCO Canada
- Employees
- COLD N/A
- BLCO N/A
- Industry
- COLD Real Estate Investment Trusts
- BLCO Ophthalmic Goods
- Sector
- COLD Real Estate
- BLCO Health Care
- Exchange
- COLD Nasdaq
- BLCO Nasdaq
- Market Cap
- COLD N/A
- BLCO 5.6B
- IPO Year
- COLD 2018
- BLCO 2022
- Fundamental
- Price
- COLD $21.46
- BLCO $15.97
- Analyst Decision
- COLD Buy
- BLCO Buy
- Analyst Count
- COLD 13
- BLCO 11
- Target Price
- COLD $28.77
- BLCO $20.00
- AVG Volume (30 Days)
- COLD 2.7M
- BLCO 436.7K
- Earning Date
- COLD 05-08-2025
- BLCO 04-30-2025
- Dividend Yield
- COLD 4.27%
- BLCO N/A
- EPS Growth
- COLD N/A
- BLCO N/A
- EPS
- COLD N/A
- BLCO N/A
- Revenue
- COLD $2,662,839,000.00
- BLCO $4,791,000,000.00
- Revenue This Year
- COLD N/A
- BLCO $6.53
- Revenue Next Year
- COLD N/A
- BLCO $5.64
- P/E Ratio
- COLD N/A
- BLCO N/A
- Revenue Growth
- COLD N/A
- BLCO 15.56
- 52 Week Low
- COLD $20.41
- BLCO $13.16
- 52 Week High
- COLD $30.45
- BLCO $21.69
- Technical
- Relative Strength Index (RSI)
- COLD 47.28
- BLCO 50.88
- Support Level
- COLD $21.15
- BLCO $15.23
- Resistance Level
- COLD $22.36
- BLCO $16.08
- Average True Range (ATR)
- COLD 0.68
- BLCO 0.32
- MACD
- COLD -0.04
- BLCO 0.10
- Stochastic Oscillator
- COLD 38.56
- BLCO 81.48
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.